Endothelin-1 in atherosclerosis and other vasculopathies

Author： Bousette Nicolas   Giaid Adel  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.81, Iss.6, 2003-06, pp. : 578-587

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chronic hypoxia differentially alters the responses of pulmonary arteries and veins to endothelin-1 and other agents

By Lal H.   Williams K.I.   Woodward B.  

European Journal of Pharmacology, Vol. 371, Iss. 1, 1999-04 ,pp. : 11-21

Elsevier

Access to resources Recommend Favorite

Synthesis and degradation of endothelin-1

By D'Orléans-Juste P   Plante M   Honoré J C   Carrier E   Labonté J  

Canadian Journal of Physiology and Pharmacology, Vol. 81, Iss. 6, 2003-06 ,pp. : 503-510

NRC Research Press

Access to resources Recommend Favorite

Impact of MCP-1 in Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 20, Iss. 28, 2014-08 ,pp. : 4580-4588

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting paraoxonase-1 in atherosclerosis

By Mackness Mike   Mackness Bharti  

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 7, 2013-10 ,pp. : 829-837

Informa Healthcare

Access to resources Recommend Favorite

Endothelin-1: a Mediator of Pulmonary Hypertension?

By MacLean M.R.  

Pulmonary Pharmacology & Therapeutics, Vol. 11, Iss. 2, 1998-04 ,pp. : 125-132

Academic Press

Access to resources Recommend Favorite